WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (99)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dumont, Y.
Right arrow Articles by Quirion, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dumont, Y.
Right arrow Articles by Quirion, R.

 Previous Article  |  Next Article 

The Journal of Neuroscience, August 1, 1998, 18(15):5565-5574

Expression and Characterization of the Neuropeptide Y Y5 Receptor Subtype in the Rat Brain

Yvan Dumont1, Alain Fournier2, and Rémi Quirion1

1 Douglas Hospital Research Center, Department of Psychiatry, McGill University, Verdun, Québec, Canada H4H 1R3, and 2 INRS-Santé, Université du Québec, Pointe-Claire, Québec, Canada H9R 1G6

The neuropeptide Y Y5 receptor subtype has generated great interest, especially regarding its possible involvement in feeding behaviors. However, its distribution and sites of expression in the mammalian brain are, in large part, unknown because of the lack of selective tools. We demonstrate in this study that specific [125I][Leu31,Pro34]PYY binding is competed in a biphasic manner by BIBP3226, a Y1 receptor antagonist, demonstrating the existence of sensitive and insensitive sites to BIBP3226. Assays performed by using [125I][Leu31,Pro34]PYY in the presence of 1 µM BIBP3226 to block the Y1 receptor subtype revealed a pharmacological profile highly similar to the cloned Y5 receptor. Moreover, results obtained with GW1229 suggest that the Y4 subtype represents only a very small proportion of the total population of NPY receptors in the rat brain. Quantitative receptor autoradiographic data revealed the discrete distribution of [125I][Leu31,Pro34]PYY/BIBP3226-insensitive Y5 sites in the rat brain, with the external plexiform layer of the olfactory bulb, the lateral septum, the anteroventral thalamic nucleus, the CA3 subfield of the ventral hippocampus, the nucleus tractus solitarius, and the area postrema being most enriched. Rather surprisingly, in the hypothalamus, a key structure modulating food intake, only low densities of Y5 binding sites were detected as well as in most other regions of the rat brain. These data suggest that the Y5 receptor protein is expressed and translated by a small percentage of hypothalamic neurons and that the effect of NPY on feeding behaviors likely is mediated by more than one class of NPY receptors. It also indicates that the Y5 receptor may be involved in other biological actions induced by NPY. Taken together, these data represent the first pharmacological demonstration of the expression and discrete localization of the Y5 receptor protein in the rat brain.

Key words: NPY/PYY receptor subtypes; Y5 receptor subtype; rat brain; autoradiographic studies; receptor binding assays


Copyright © 1998 Society for Neuroscience  0270-6474/98/18155565-10$05.00/0


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
L. Pinilla, R. Fernandez-Fernandez, J. Roa, J. M. Castellano, M. Tena-Sempere, and E. Aguilar
Selective role of neuropeptide Y receptor subtype Y2 in the control of gonadotropin secretion in the rat
Am J Physiol Endocrinol Metab, November 1, 2007; 293(5): E1385 - E1392.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
M. M. Kamiji and A. Inui
Neuropeptide Y Receptor Selective Ligands in the Treatment of Obesity
Endocr. Rev., October 1, 2007; 28(6): 664 - 684.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. Veliskova and L. Velisek
{beta}-Estradiol Increases Dentate Gyrus Inhibition in Female Rats via Augmentation of Hilar Neuropeptide Y
J. Neurosci., May 30, 2007; 27(22): 6054 - 6063.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
M. Fry, T. D. Hoyda, and A. V. Ferguson
Making Sense of It: Roles of the Sensory Circumventricular Organs in Feeding and Regulation of Energy Homeostasis
Experimental Biology and Medicine, January 1, 2007; 232(1): 14 - 26.
[Abstract] [Full Text] [PDF]


Home page
Phil Trans R Soc BHome page
B Beck
Neuropeptide Y in normal eating and in genetic and dietary-induced obesity
Phil Trans R Soc B, July 29, 2006; 361(1471): 1159 - 1185.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y.-S. Han, S. Bastianetto, Y. Dumont, and R. Quirion
Specific Plasma Membrane Binding Sites for Polyphenols, Including Resveratrol, in the Rat Brain
J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 238 - 245.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Dumont, E. Moyse, A. Fournier, and R. Quirion
Evidence for the Existence of an Additional Class of Neuropeptide Y Receptor Sites in Rat Brain
J. Pharmacol. Exp. Ther., October 1, 2005; 315(1): 99 - 108.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
S. Stanley, K. Wynne, B. McGowan, and S. Bloom
Hormonal Regulation of Food Intake
Physiol Rev, October 1, 2005; 85(4): 1131 - 1158.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
L. F. Faulconbridge, H. J. Grill, and J. M. Kaplan
Distinct Forebrain and Caudal Brainstem Contributions to the Neuropeptide Y Mediation of Ghrelin Hyperphagia
Diabetes, July 1, 2005; 54(7): 1985 - 1993.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
K. Wynne, S. Stanley, B. McGowan, and S. Bloom
Appetite control
J. Endocrinol., February 1, 2005; 184(2): 291 - 318.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P. Bonaventure, D. Nepomuceno, C. Mazur, B. Lord, D. A. Rudolph, J. A. Jablonowski, N. I. Carruthers, and T. W. Lovenberg
Characterization of N-(1-Acetyl-2,3-dihydro-1H-indol-6-yl)-3-(3-cyano-phenyl)-N-[1-(2-cyclopentyl-ethyl)-piperidin-4yl]acrylamide (JNJ-5207787), a Small Molecule Antagonist of the Neuropeptide Y Y2 Receptor
J. Pharmacol. Exp. Ther., March 1, 2004; 308(3): 1130 - 1137.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. D. Raposinho, T. Pedrazzini, R. B. White, R. D. Palmiter, and M. L. Aubert
Chronic Neuropeptide Y Infusion into the Lateral Ventricle Induces Sustained Feeding and Obesity in Mice Lacking Either Npy1r or Npy5r Expression
Endocrinology, January 1, 2004; 145(1): 304 - 310.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
M. M. Berglund, P. A. Hipskind, and D. R. Gehlert
Recent Developments in Our Understanding of the Physiological Role of PP-Fold Peptide Receptor Subtypes
Experimental Biology and Medicine, March 1, 2003; 228(3): 217 - 244.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
D. K. Sindelar, P. Mystkowski, D. J. Marsh, R. D. Palmiter, and M. W. Schwartz
Attenuation of Diabetic Hyperphagia in Neuropeptide Y-Deficient Mice
Diabetes, March 1, 2002; 51(3): 778 - 783.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
H. E. De Wardener
The Hypothalamus and Hypertension
Physiol Rev, October 1, 2001; 81(4): 1599 - 1658.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
F. Zammaretti, G. Panzica, and C. Eva
Fasting, Leptin Treatment, and Glucose Administration Differentially Regulate Y1 Receptor Gene Expression in the Hypothalamus of Transgenic Mice
Endocrinology, September 1, 2001; 142(9): 3774 - 3782.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
M. W. Y. Ho, A. G. Beck-Sickinger, and W. F. Colmers
Neuropeptide Y5 Receptors Reduce Synaptic Excitation in Proximal Subiculum, But Not Epileptiform Activity in Rat Hippocampal Slices
J Neurophysiol, February 1, 2000; 83(2): 723 - 734.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
K. A. Nichol, A. Morey, M. H. Couzens, J. Shine, H. Herzog, and A. M. Cunningham
Conservation of Expression of Neuropeptide Y5 Receptor between Human and Rat Hypothalamus and Limbic Regions Suggests an Integral Role in Central Neuroendocrine Control
J. Neurosci., December 1, 1999; 19(23): 10295 - 10304.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. J. Marsh, S. C. Baraban, G. Hollopeter, and R. D. Palmiter
Role of the Y5 neuropeptide Y receptor in limbic seizures
PNAS, November 9, 1999; 96(23): 13518 - 13523.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Yokosuka, P. S. Kalra, and S. P. Kalra
Inhibition of Neuropeptide Y (NPY)-Induced Feeding and c-Fos Response in Magnocellular Paraventricular Nucleus by a NPY Receptor Antagonist: A Site of NPY Action
Endocrinology, October 1, 1999; 140(10): 4494 - 4500.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
P. D. Raposinho, P. Broqua, D. D. Pierroz, A. Hayward, Y. Dumont, R. Quirion, J.-L. Junien, and M. L. Aubert
Evidence That the Inhibition of Luteinizing Hormone Secretion Exerted by Central Administration of Neuropeptide Y (NPY) in the Rat Is Predominantly Mediated by the NPY-Y5 Receptor Subtype
Endocrinology, September 1, 1999; 140(9): 4046 - 4055.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
S. P. Kalra, M. G. Dube, S. Pu, B. Xu, T. L. Horvath, and P. S. Kalra
Interacting Appetite-Regulating Pathways in the Hypothalamic Regulation of Body Weight
Endocr. Rev., February 1, 1999; 20(1): 68 - 100.
[Abstract] [Full Text]



-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-